InProTher presentation by Peter J. Holst

InProTher treats cancer by target tumor virus within the human genome. In this video you can learn more about the company, where InProTher is presented by Associate Professor Peter Johannes Holst.

Related news

View all news
SIRION Biotech Licenses Adenovirus Technology to Danish Startup, InProTher for its Novel Immunotherapy Design Targeting Endogenous Retrovirus (ERV)
Blog_post_1
Inprother_Jordi_Naval_CEO
DEMODAY
InProTher ApS
Novo Nordisk BioInnovation Institute COBIS
CVR: 33968426
Ole Maaløes Vej 3, 2200 Copenhagen N, Denmark
Copyright 2023 ©
Privacy Policy | Legal Advice
InProTher ApS
Novo Nordisk BioInnovation Institute COBIS
CVR: 33968426
Ole Maaløes Vej 3, 2200 Copenhagen N, Denmark
Copyright 2023 ©
Privacy Policy | Legal Advice